Invesco India Balanced Advantage Fund - Growth
Category: Hybrid: Dynamic Asset Allocation
Launch Date: 04-10-2007
AUM:
₹ 730.58 Cr
Expense Ratio
2.21%
Benchmark
NIFTY 50 Hybrid Composite debt 50:50 Index
ISIN
INF205K01213
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Amit Ganatra, Dhimant Kothari
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Invesco India Balanced Advantage Fund - Growth | 23.81 | 12.45 | 11.25 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
48.3
Last change
0.11 (0.2277%)
Fund Size (AUM)
₹ 730.58 Cr
Performance
9.94% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The fund aims to generate long term capital growth by investing in equity and equity related instrument of companies across market capitalisation. The fund would follow a focused stock selection approach. In order to insure sufficient diversification the scheme would invest in companies from not less than five sectors and not more than ten sectors. The exposure toward a single stock would be to a minimum of 2% and maximum of 10%.
Fund Manager
Amit Ganatra, Dhimant Kothari
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Others | 10.6 |
| Invesco India Short Duration Fund Direct-Growth | 9.75 |
| ICICI Bank Ltd. | 7.79 |
| Others | 7.41 |
| Invesco India Money Market Fund Direct-Growth | 6.5 |
| Tata Consultancy Services Ltd. | 5.55 |
| Reliance Industries Ltd. | 4.77 |
| NTPC Ltd. | 3.45 |
| Avenue Supermarts Ltd. | 2.8 |
| Sun Pharmaceutical Industries Ltd. | 2.77 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Others | 18.01 |
| Unclassified | 16.25 |
| Financial | 14.18 |
| Healthcare | 7.97 |
| Sovereign | 6.74 |
| Capital Goods | 6.45 |
| Technology | 5.39 |
| Services | 5.0 |
| Energy | 3.78 |
| Automobile | 3.27 |